Saturday, July 11, 2026

Drug profile · INN

karelizumab

karelizumab is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — karelizumab
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

karelizumab is an FDA-listed pharmaceutical active ingredient.

Key facts

INN karelizumab

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Karelizumab combined with etoposide and cisplatin Phase 2 · LianBio · Carcinoma

Frequently asked questions

What is karelizumab?

karelizumab is an FDA-listed pharmaceutical active ingredient.